How Is The Demand For A Bone Densitometer

The global bone densitometer market is anticipated to grasp USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the prediction period. In 2021, North America accounted for the main part of the bone densitometer market, shadowed by Europe. The evolution of the bone densitometers market in North America is chiefly driven by the high customer consciousness, upsurge in healthcare spending, increasing occurrence of osteoporosis, and the attendance of Bone Densitometer Manufacturers in the area. Bone densitometers are used to control and identify osteoporosis, osteopenia, and illnesses leading to the deterioration of bones, such as osteomalacia, osteoarthritis, and osteoporotic ruptures. Bone densitometers are used to gauge the bone density of patients, which controls the probability of these illnesses occurring.
Bestowing to the International Osteoporosis Foundation (IOF), osteoporosis reasons more than 8.9 million ruptures annually—internationally, an osteoporotic rupture happens every three seconds. According to a study directed by the IOF, it is projected that the number of people with osteoporosis and osteopenia in China is projected to surge to 286.6 million by 2020 and 533.3 million by 2050. The occurrence of hip ruptures has by now increased two- to three-fold in most Asian nations during the last 30 years. By 2050, more than 50% of all osteoporotic ruptures will arise in Asia. With the rising occurrence of osteoporosis, the request for effective diagnostic methods will surge meaningfully, thus driving the request for bone densitometers.